Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
The goal of the PRCRP is to improve quality of life by decreasing the impact of cancer on active duty Service members, their families, Veterans, and the American public.
Característiques principals
To be considered for funding, applications for the FY20 PRCRP Virtual Cancer Center Director Award must address at least one of the FY20 PRCRP Topic Areas as directed by Congress. Congressional language for the FY20 PRCRP provides funds for applications focused on cancers not addressed in the breast, kidney, lung, pancreatic, prostate, ovarian, rare cancer, and melanoma research programs. Applications in the areas of breast, kidney, lung (excluding mesothelioma), prostate, pancreatic, rare cancer, ovarian cancer or melanoma will not be accepted. The inclusion of the individual Rare Cancer Research Program shall not prohibit the PRCRP from funding the below mentioned cancers or cancer subtypes that may be rare by definition. The FY20 PRCRP Topic Areas are listed below.
  • Bladder cancer
  • Blood cancers
  • Brain cancer
  • Colorectal cancer
  • New for FY20: Esophageal cancer
  • New for FY20: Head and Neck cancer
  • Immunotherapy1
  • Liver cancer
  • Mesothelioma
  • New for FY20: Metastatic cancers
  • Neuroblastoma
  • Pediatric brain tumors
  • Pediatric, adolescent, and young adult cancers2
  • Stomach cance
    For research funded under the FY20 PRCRP Topic Area metastatic cancers research proposed must be targeted to cancer that has spread from its original location to another place in the body, representing what is known as stage III and stage IV cancer diagnoses. While recent research has revealed that there is a genetic basis for susceptibility or resistance to metastasis, more research is needed to develop a comprehensive understanding of this complex process. Applications to the metastatic cancer topic area should focus on the process of metastasis and not the cancer type (i.e., an agnostic interrogation of the process of metastasis).All research funded under the FY20 PRCRP must follow Congressional language (i.e., prohibited cancers)
    		•
    Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: cbarnwell@imim.es Ext.: 1670
    Marta López: mlopez4@imim.es Ext.: 1576
    Convocatòria (URL)
    http://cdmrp.army.mil/funding/prcrp
    Dotació
  • Career Development Award - Fellow Option: $400,000
  • Career Development Award – Virtual Cancer Center Scholar Option: $800,000
  • Idea Award: $500,000
  • Impact award: $1,000,000
  • Behavioral Health Science Award: $1,000,000
  • Translational Team Science Award:$1,500,000
    • Durada
  • Career Development Award - Fellow Option: 3 years
  • Career Development Award – Virtual Cancer Center Scholar Option: 4 years
  • Idea Award: 3 years
  • Impact award: 3 years
  • Behavioral Health Science Award: 4 years
  • Translational Team Science Award: 4 years
    • AVÍS IMPORTANT
    Pre-Application (Preproposal) deadline:
  • Career Development Award - Fellow Option: July 30, 2020
  • Career Development Award – Virtual Cancer Center Scholar Option: July 30, 2020
  • Idea Award: May 14, 2020
  • Impact award: 14 May 2020
  • Behavioral Health Science Award: July 30, 2020
  • Translational Team Science Award: July 30, 2020
    		•

    Arxius

    Arxiu
    FY20_20prcrpreftable.pdf
    FY20-PRCRP-GAI.pdf